Medicenna Therapeutics (MDNA) Short Interest Ratio & Short Volume → You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad) Free MDNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipSocial Media Medicenna Therapeutics Short Interest DataCurrent Short Volume109,400 sharesPrevious Short Volume164,200 sharesChange Vs. Previous Month-33.37%Dollar Volume Sold Short$32,163.60Short Interest Ratio / Days to Cover0.5Last Record DateOctober 15, 2023Outstanding Shares69,637,000 sharesFloat Size53,170,000 sharesShort Percent of Float0.21%Today's Trading Volume1,267,200 sharesAverage Trading Volume160,047 sharesToday's Volume Vs. Average792% Short Selling Medicenna Therapeutics ? Sign up to receive the latest short interest report for Medicenna Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMDNA Short Interest Over TimeMDNA Days to Cover Over TimeMDNA Percentage of Float Shorted Over Time Ad InvestorPlaceNow Open: Crypto emergency updateDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. Medicenna Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2023109,400 shares $32,163.60 -33.4%0.2%0.5 $0.29 9/30/2023164,200 shares $48,422.58 -41.0%0.3%0.7 $0.29 9/15/2023278,200 shares $80,678.00 +37.6%0.7%1.2 $0.29 8/31/2023202,200 shares $74,814.00 -22.0%0.5%1 $0.37 8/15/2023259,200 shares $106,012.80 +13.8%0.6%1.4 $0.41 7/31/2023227,700 shares $111,390.84 +56.6%0.5%1.3 $0.49 Get the Latest News and Ratings for MDNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medicenna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/2023145,400 shares $70,838.88 -27.8%0.4%1.7 $0.49 6/30/2023201,500 shares $97,062.55 +19.8%0.5%2.4 $0.48 6/15/2023168,200 shares $104,284.00 +9.2%0.4%2 $0.62 5/31/2023154,100 shares $90,934.41 -46.5%0.4%1.9 $0.59 5/15/2023287,900 shares $198,651.00 +20.3%0.7%3.7 $0.69 4/30/2023239,400 shares $153,311.76 +5.8%0.6%2.9 $0.64 4/15/2023226,300 shares $135,531.07 +3.8%0.5%2.3 $0.60 3/31/2023218,100 shares $137,315.76 +9.9%0.5%2.1 $0.63 3/15/2023198,500 shares $111,160.00 -15.3%0.5%1.7 $0.56 2/28/2023234,400 shares $144,835.76 -15.6%0.6%1.8 $0.62 2/15/2023277,600 shares $194,042.40 +23.7%0.7%1.9 $0.70 1/31/2023224,400 shares $164,126.16 +5.9%0.5%1.3 $0.73 1/15/2023211,900 shares $127,140.00 +59.3%0.5%1.2 $0.60 12/30/2022133,000 shares $60,914.00 +29.3%0.3%0.8 $0.46 12/15/2022102,900 shares $52,479.00 +86.8%0.2%0.6 $0.51 11/30/202255,100 shares $29,203.00 -68.8%0.1%0.3 $0.53 11/15/2022176,600 shares $88,300.00 -24.4%0.4%0.9 $0.50 10/31/2022233,700 shares $175,275.00 -23.5%0.6%0.8 $0.75 10/15/2022305,400 shares $250,428.00 +57.3%0.8%0.9 $0.82 9/30/2022194,200 shares $161,108.32 -34.7%0.5%0.6 $0.83 9/15/2022297,300 shares $267,272.70 +146.5%0.7%1 $0.90 8/31/2022120,600 shares $111,205.26 -7.7%0.3%0.4 $0.92 8/15/2022130,600 shares $127,988.00 -16.3%0.3%0.5 $0.98 7/31/2022156,100 shares $240,394.00 +4.8%0.4%1.4 $1.54 7/15/2022149,000 shares $205,620.00 -8.3%0.4%2 $1.38 6/30/2022162,500 shares $188,500.00 +24.0%0.4%1.6 $1.16 6/15/2022131,100 shares $108,813.00 -36.4%0.4%1.2 $0.83 5/31/2022206,000 shares $205,382.00 -8.0%0.6%2 $1.00 5/15/2022224,000 shares $246,400.00 +12.7%0.6%2 $1.10 4/30/2022198,700 shares $218,570.00 +138.5%0.5%1.7 $1.10 4/15/202283,300 shares $103,292.00 +3.6%0.2%0.8 $1.24 3/31/202280,400 shares $102,903.96 +10.1%0.2%0.8 $1.28 3/15/202273,000 shares $97,090.00 -60.4%0.2%0.6 $1.33 2/28/2022184,200 shares $276,300.00 -29.6%0.5%1.3 $1.50Now Open: Crypto emergency update (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. MDNA Short Interest - Frequently Asked Questions What is Medicenna Therapeutics' current short interest? Short interest is the volume of Medicenna Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 109,400 shares of MDNA short. 0.21% of Medicenna Therapeutics' shares are currently sold short. Learn More on Medicenna Therapeutics' current short interest. What is a good short interest percentage for Medicenna Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.21% of Medicenna Therapeutics' floating shares are currently sold short. Is Medicenna Therapeutics' short interest increasing or decreasing? Medicenna Therapeutics saw a decrease in short interest during the month of October. As of October 15th, there was short interest totaling 109,400 shares, a decrease of 33.4% from the previous total of 164,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Medicenna Therapeutics' float size? Medicenna Therapeutics currently has issued a total of 69,637,000 shares. Some of Medicenna Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Medicenna Therapeutics currently has a public float of 53,170,000 shares. How does Medicenna Therapeutics' short interest compare to its competitors? 0.21% of Medicenna Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Medicenna Therapeutics: TFF Pharmaceuticals, Inc. (3.44%), Hepion Pharmaceuticals, Inc. (1.47%), Elevai Labs, Inc. (0.19%), Monopar Therapeutics Inc. (2.29%), Moleculin Biotech, Inc. (2.09%), Biofrontera Inc. (0.95%), Eterna Therapeutics Inc. (1.42%), Aeterna Zentaris Inc. (0.45%), Guardion Health Sciences, Inc. (13.71%), Molecular Templates, Inc. (1.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.82 billion), T-Mobile US, Inc. ($3.69 billion), Occidental Petroleum Co. ($2.90 billion), TC Energy Co. ($2.74 billion), Tractor Supply ($2.28 billion), Rivian Automotive, Inc. ($1.92 billion), Moderna, Inc. ($1.77 billion), Celsius Holdings, Inc. ($1.72 billion), Coinbase Global, Inc. ($1.66 billion), and Royal Caribbean Cruises Ltd. ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short Medicenna Therapeutics stock? Short selling MDNA is an investing strategy that aims to generate trading profit from Medicenna Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medicenna Therapeutics? A short squeeze for Medicenna Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MDNA, which in turn drives the price of the stock up even further. How often is Medicenna Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MDNA, twice per month. The most recent reporting period available is October, 15 2023. More Short Interest Resources from MarketBeat Related Companies: TFFP Short Squeeze HEPA Short Squeeze ELAB Short Squeeze MNPR Short Squeeze MBRX Short Squeeze BFRI Short Squeeze ERNA Short Squeeze AEZS Short Squeeze GHSI Short Squeeze MTEM Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MDNA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving Trends